CD163 and leiomyosarcoma: The number of TAMs in tissue from sarcoma patients indicates that M2-like macrophages expressing CD163 are correlated with poor prognosis in patients with leiomyosarcoma [41,42], myxoid liposarcoma [43], and osteosarcoma [15].